Article

Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.

Post Graduation Program in Basic and Applied Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Avenue Bandeirantes, 3900, Ribeirão Preto, São Paulo 14049-900, Brazil.
Agents and Actions (Impact Factor: 1.59). 01/2012; 61(4):337-48. DOI: 10.1007/s00011-011-0415-5
Source: PubMed

ABSTRACT Endothelins (ETs) are involved in several inflammatory events. The present study investigated the efficacy of bosentan, a dual ETA/ETB receptor antagonist, in collagen-induced arthritis (CIA) in mice.
CIA was induced in DBA/1J mice. Arthritic mice were treated with bosentan (100 mg/kg) once a day, starting from the day when arthritis was clinically detectable.
CIA progression was assessed by measurements of visual clinical score, paw swelling and hypernociception. Histological changes, neutrophil infiltration and pro-inflammatory cytokines were evaluated in the joints. Gene expression in the lymph nodes of arthritic mice was evaluated by microarray technology. PreproET-1 mRNA expression in the lymph nodes of mice and in peripheral blood mononuclear cells (PBMCs) was evaluated by real-time PCR. The differences were evaluated by one-way ANOVA or Student's t test.
Oral treatment with bosentan markedly ameliorated the clinical aspects of CIA (visual clinical score, paw swelling and hyperalgesia). Bosentan treatment also reduced joint damage, leukocyte infiltration and pro-inflammatory cytokine levels (IL-1β, TNFα and IL-17) in the joint tissues. Changes in gene expression in the lymph nodes of arthritic mice returned to the levels of the control mice after bosentan treatment. PreproET mRNA expression increased in PBMCs from rheumatoid arthritis (RA) patients but returned to basal level in PBMCs from patients under anti-TNF therapy. In-vitro treatment of PBMCs with TNFα upregulated ET system genes.
These findings indicate that ET receptor antagonists, such as bosentan, might be useful in controlling RA. Moreover, it seems that ET mediation of arthritis is triggered by TNFα.

2 Bookmarks
 · 
108 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Endothelins are peptides described initially as potent vasoactive mediators. Recently, studies reported that endothelins can modulate the production and release of cytokines by immune cells. In turn, cytokines are involved in depression disorders and also in the effectiveness of some antidepressants. Therefore, we investigated the effects of treating mice with bosentan, a mixed endothelin receptor antagonist, in widely used models for assessing antidepressant activity of compounds, the forced swimming (FST) and the tail suspension tests (TST). Moreover, the influence of bosentan treatment on circulating IL-6 levels was also addressed after FST. The results show that bosentan treatment induced a bell shaped dose-dependent antidepressant-like effect with increase in circulating IL-6 levels in animals exposed to FST. Bosentan also presented antidepressant-like effect in TST. Similar results were obtained with nortriptyline treatment in the FST and TST. Possible anxiogenic effect of bosentan was excluded using the elevated plus maze test. Therefore, this is the first study to demonstrate the antidepressant-like activity of bosentan in mice, unveiling a previous unrecognized role of endothelin in depression and its possible relation with increased circulating IL-6 levels.
    Neuroscience Letters 12/2013; · 2.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: The aim of this study was to assess whether apocynin, an nicotinamide adenine dinucleotide phosphate (NADPH) oxidase blocker, influences lipid peroxidation TBARS, hydrogen peroxide (H2O2) content, protein level, heart edema, tumor necrosis factor α (TNF-α) concentration or the glutathione redox system in heart homogenates obtained from endothelin 1 (ET-1)-induced oxidative stress rats. Methods: Experiments were carried out on adult maleWistar-Kyoto rats. The animals were divided into 4 groups: Group I: saline-treated control; Group II: saline followed by ET-1 (3 μg/kg b.w., iv); Group III: apocynin (5 mg/kg b.w., iv) administered half an hour before saline; Group IV: apocynin (5 mg/kg b.w., iv) administered half an hour before ET-1 (3 μg/kg b.w., iv). Results: Injection of ET-1 alone showed a significant (p < 0.001) increase in thiobarbituric acid reactive substances (TBARS) and the hydrogen peroxide level (p < 0.01) vs. control, as well as a decrease (p < 0.001) in the GSH level. Apocynin significantly decreased TBARS (p < 0.001) and H2O2 (p < 0.05) level (vs. control) as well as improved protein level (p < 0.001) in the heart. Apocynin also prevented ET-1-induced heart edema (p < 0.05). The presence of ET-1 increased the concentration of TNF-α (p < 0.05) while apocynin decreased it (p < 0.05). Our results indicate that ET-1 may induce oxidative stress in heart tissue by reducing the GSH/GSSG ratio, stimulating lipid peroxidation and increasing TNF-α concentration. Apocynin diminished these measures of oxidative stress and TNF-α. Conclusion: ET-1-induced formation of ROS in the heart is at least partially regulated via NADPH oxidase.
    Pharmacological reports: PR 01/2013; 65(4):898-905. · 1.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Endothelin-1(ET-1) is a 21-amino-acid peptide with multifunctional regulation. Initial research indicated that ET-1 is related to the inflammatory pathogenesis of periodontitis and involved in the regulation of cytokines, but the mechanisms involved remain unclear. The primary aim of this study was to investigate how ET-1 affects proinflammatory cytokine expression in human periodontal ligament (hPDL) cells. Methods: hPDL cells were obtained from both healthy (H-hPDL cells) and periodontitis-affected periodontal tissues (P-hPDL cells). The H-hPDL cells and P-hPDL cells were treated with ET-1 (1nM, 10nM, and 100nM) for 12, 24, and 48 hours(hrs). The untreated cells served as a normal control. To confirm the specificity of the ET-1 effects, we used 100nM of the specific endothelin A receptor(ETA) antagonist BQ123, and 100nM of the specific endothelin B receptor (ETB) antagonist BQ788 , as negative control. To examine the signaling pathways and molecular mechanisms involved in ET-1-mediated cytokine expression, The H-hPDL cells and P-hPDL cells were pre-treated with specific inhibitors for signal-regulated kinase (ERK1/2)(PD98059), c-Jun N-terminal kinase(JNK)(SP600125), and p38 kinase(SB203580) for 1 hrs before 100nM ET-1 stimulation. The tumour necrosis factor-alpha (TNF-α), interleukin(IL)-1β (IL-1β) and IL-6 mRNA and protein levels were evaluated by quantitative real-time PCR and ELISA, respectively. Results: ET-1 dose- and time- dependently induced the production of proinflammatory cytokines TNF-α, IL-1β, and IL-6 by H-hPDL cells and P-hPDL cells at both mRNA and protein levels. However, The ETA and ETB receptor antagonists inhibited the stimulatory effects of ET-1 on inflammatory cytokine expression in H-hPDL cells and P-hPDL cells. Furthermore, inhibitors of the Mitogen-activated protein kinases (MAPKs) significant reduced in ET-1-stimulated TNF-α, IL-1β, and IL-6 expression in H-hPDL cells and P-hPDL cells. Conclusion: ET-1 may be involved in the inflammatory process of periodontitis, at least in part, by stimulating proinflammatory cytokine production via MAPKs pathway in hPDL cells.
    Journal of Periodontology 05/2013; · 2.40 Impact Factor

Full-text

View
15 Downloads
Available from
May 21, 2014